Related Experiment Video
Updated: May 28, 2026

Monitoring Leucine-Rich Repeat Containing 8 Channel (LRRC8/VRAC) Activity Using Sensitized-Emission Förster Resonance Energy Transfer (SE-FRET)
Published on: August 9, 2024
The LRRC26 protein selectively alters the efficacy of BK channel activators
Janos Almassy1, Ted Begenisich
1Department of Pharmacology and Physiology, University of Rochester School of Medicine and Dentistry, Rochester, New York 14642, USA.
Abstract:
Large conductance, Ca(2+)-activated K channel proteins are involved in a wide range of physiological activities, so there is considerable interest in the pharmacology of large conductance calcium-activated K (BK) channels. One potent activator of BK channels is mallotoxin (MTX), which produces a very large hyperpolarizing shift of the voltage gating of heterologously expressed BK channels and causes a dramatic increase in the activity of BK channels in human smooth muscle cells. However, we found that MTX shifted the steady-state activation of BK channels in native parotid acinar cells by only 6 mV. This was not because the parotid BK isoform (parSlo) is inherently insensitive to MTX as MTX shifted the activation of heterologously expressed parSlo channels by 70 mV. Even though MTX had a minimal effect on steady-state activation of parotid BK channels, it produced an approximate 2-fold speeding of the channel-gating kinetics. The BK channels in parotid acinar cells have a much more hyperpolarized voltage activation range than BK channels in most other cell types. We found that this is probably attributable to an accessory protein, LRRC26, which is expressed in parotid glands: expressed parSlo + LRRC26 channels were resistant to the actions of MTX. Another class of BK activators is the benzimidazalones that includes 1,3-dihydro-1-(2-hydroxy-5-(trifluoromethyl)phenyl)-5-(trifluoromethyl)-2H-benzimidazol-2-one (NS-1619). Although the LRRC26 accessory protein strongly inhibited the ability of MTX to activate BK channels, we found that it had only a small effect on the action of NS-1619 on BK channels. Thus, the LRRC26 BK channel accessory protein selectively alters the pharmacology of BK channels.
Insights
Mallotoxin (MTX) activates large conductance calcium-activated potassium (BK) channels, but its effect is reduced by the accessory protein LRRC26 in native parotid cells. LRRC26 selectively alters BK channel pharmacology.
Area of Science:
- Biophysics
- Molecular Biology
- Pharmacology
Background:
- Large conductance, calcium-activated potassium (BK) channels are crucial for numerous physiological processes.
- Mallotoxin (MTX) is a known potent activator of BK channels, significantly altering their voltage gating and activity.
- Understanding BK channel pharmacology is vital due to their diverse physiological roles.
Purpose of the Study:
- To investigate the differential effects of mallotoxin (MTX) on BK channels in native parotid acinar cells versus heterologously expressed channels.
- To determine the role of the accessory protein LRRC26 in modulating the response of parotid BK channels to MTX and other activators.
- To elucidate the selective pharmacological impact of LRRC26 on BK channel activation.
Main Methods:
- Electrophysiological recordings (e.g., patch-clamp) to measure BK channel activity and gating kinetics.
- Heterologous expression of BK channel isoforms (parSlo) with and without the LRRC26 accessory protein.
- Application of pharmacological agents, including MTX and NS-1619, to assess their effects on channel function.
Main Results:
- MTX caused a minimal shift in steady-state activation of BK channels in native parotid acinar cells (6 mV), contrasting with large shifts in heterologously expressed channels (70 mV).
- Despite minimal steady-state effects, MTX approximately doubled the gating kinetics of BK channels in parotid cells.
- The accessory protein LRRC26, expressed in parotid glands, rendered parSlo BK channels resistant to MTX activation but had minimal impact on NS-1619 efficacy.
- Parotid BK channels exhibit a more hyperpolarized voltage activation range, potentially due to LRRC26.
Conclusions:
- The accessory protein LRRC26 selectively alters the pharmacology of large conductance calcium-activated potassium channels.
- LRRC26 confers resistance to MTX activation while largely preserving sensitivity to benzimidazolone activators like NS-1619.
- These findings highlight the crucial role of accessory proteins in fine-tuning BK channel function and drug response in native tissues.
Related Concept Videos
Ligand-Gated Ion Channel Receptor: Gating Mechanism
Antihypertensive Drugs: Action of Calcium Channel Blockers
The Two-State Receptor Model
The binding affinity of a drug determines its interaction with one...
Antiarrhythmic Drugs: Class III Agents as Potassium Channel Blockers
Regulation of Nuclear Protein Sorting
GPCR Desensitization

